California Medicaid Skilled Home Health Agency, 1990-Founded CA Provider

$6.5M

Revenue

$900K

SDE

5.0x

Multiple

Subscribe Free

Read the full deal writeup

Get Free Access

Already a member? Sign in

Full Editorial Writeup

This is a well-established skilled home health agency founded in 1990 that serves Medicaid patients across California. It delivers medically necessary, physician-ordered in-home clinical care spanning skilled nursing, physical, occupational and speech therapy, wound care, medication management, disease management and post-acute recovery coordination. The company runs from a leased administrative office with roughly 110 full-time employees and holds full licensure and accreditation.

The agency generates about $6.5 million in gross revenue with $900,000 of EBITDA, a roughly 14 percent margin. Its value sits in the intangibles: long-standing referral relationships with hospitals, physicians, managed care organizations and community providers, plus a licensed and accredited operating footprint that a new entrant would need years to replicate. Caregiver retention is described as strong, which matters enormously in a labor-constrained clinical business.

The listing positions the business as a platform for strategic acquirers, regional operators and PE-backed healthcare consolidators looking to expand a California presence. That framing is fair: home health is riding durable demographic tailwinds as California's aging population grows and payers push care toward lower-cost, community-based settings. The owner is retiring and the reason for selling is clean.

Why we like it

Earnings quality is grounded in Medicaid-reimbursed, physician-ordered clinical care, which produces steady, non-discretionary billings rather than one-off project revenue. At $6.5M revenue and $900K EBITDA the 14 percent margin is modest but believable for a labor-heavy home health operation, and the 5x multiple is in line with sector comps. The bulk of value is the licensure, accreditation and referral book rather than fragile goodwill.
The moat is regulatory and relationship-driven. Full licensure and accreditation plus 35 years of referral history with hospitals, physicians and managed care organizations create real barriers to entry that a startup cannot quickly duplicate. Strong caregiver retention in a market where clinical staffing is the binding constraint is a genuine competitive edge.
Market tailwinds are as durable as they come: California's aging population is expanding and payers are actively steering patients toward lower-cost in-home care versus facility-based settings. This is a demand curve that grows through recessions because the services are medically necessary and reimbursed by government payers. Demographics do the compounding for you here.
This is a natural bolt-on for a regional operator or PE-backed platform. An acquirer with existing back-office, billing and compliance infrastructure can strip duplicative overhead and expand census through the same referral network. For a hands-on operator, the growth levers (adjacent geographies, deeper managed Medicaid relationships, specialized programs) are already identified and executable.

How to improve it

Audit and optimize the payer mix and reimbursement rates in the first 90 days. Being nearly all-Medicaid caps margins, so identify whether the agency can add Medicare-certified skilled visits or managed care contracts that pay materially better per episode. Even a modest shift toward higher-reimbursement episodes moves the 14 percent margin meaningfully.
Attack clinician utilization and scheduling density. In home health, drive time and idle capacity destroy margin, so tighten routing so nurses and therapists see more patients per shift within tighter geographic clusters. Higher visits-per-clinician-per-day flows almost directly to EBITDA.
Deepen the managed Medicaid organization relationships into preferred-provider or value-based arrangements. Locking in referral volume through contracted status with MCOs reduces census volatility and raises the switching cost for those payers. This converts loose referral goodwill into something closer to contractual recurring revenue.
Launch specialized clinical programs the listing already flags: chronic disease management, wound care and post-acute recovery. These raise acuity, justify higher reimbursement, and differentiate the agency to hospital discharge planners looking to reduce readmissions. Position them explicitly as readmission-reduction offerings to referral partners.
Build a formal recruiting and retention engine for clinical staff. Since census growth is gated by hiring, invest in referral bonuses, flexible scheduling and clear career pathing to keep the strong retention the listing cites while adding capacity. Every clinician hired is directly monetizable given existing referral demand.
Tighten billing, documentation and compliance systems before any expansion. Medicaid clawbacks and survey deficiencies are the single largest downside risk in this business, so instrument denial rates, documentation completeness and audit readiness with real dashboards. Clean compliance also makes the asset far more attractive at your eventual exit.
Use the platform for tuck-in acquisitions of smaller California agencies. The infrastructure, licensure and back office are already built, so acquiring sub-scale competitors and folding their census onto your overhead is highly accretive. This is the fastest path to the regional roll-up the listing itself suggests.

Diligence notes

Scrutinize the Medicaid reimbursement exposure and any pending rate changes. California Medi-Cal rate schedules and any planned cuts directly determine the durability of the $900K EBITDA, so model sensitivity to reimbursement pressure. Confirm there are no material clawbacks, audits, or recoupment liabilities outstanding.
Verify licensure, accreditation and survey history in detail. Pull the most recent state survey and accreditation reports, any deficiency citations, corrective action plans, and confirm the license is transferable under a change-of-ownership without a gap. A license or accreditation problem can halt billing entirely.
Analyze referral source concentration and stability. Long-standing relationships are the core asset, so quantify what share of census comes from the top few hospitals, physician groups and MCOs, and confirm those are durable rather than tied to a departing owner. Referral concentration is the hidden fragility in home health.
Assess clinician staffing and dependence on the exiting owner. With 110 employees, confirm the management team can run operations without the retiring owner, and stress-test caregiver turnover, contractor versus W-2 classification, and any wage pressure. Verify the reason for selling is genuinely retirement and negotiate a robust transition given the owner's referral relationships.
Reconcile the revenue figures cited. The description references both approximately $6.0 million and the header states $6.5 million gross revenue, so confirm audited or tax-return revenue and normalize the EBITDA add-backs. Validate the 14 percent margin against payroll and clinician cost detail before accepting the 5x multiple.

Source

Originally listed on BizBuySell. View original listing →